Gaafar Rabab
The Department of Medical Oncology, National Cancer Institute, Cairo University.
J Egypt Natl Canc Inst. 2005 Sep;17(3):132-8.
Publications may represent accomplishment in academic medicine, primary documentation of research data, evidence of expertise through writing an authoritative review paper or book chapter or a major determinant in achieving academic promotion and career development. Editors and reviewers appreciate receiving manuscripts that are easy to read and edit. Much of the information in journals instructions to authors is designed to accomplish that goal in ways that meet each journal's particular editorial needs. The CONsolidated Standards of Reporting Trial (CONSORT) statement is an important research tool that takes an evidence-based approach to improve the quality of reports of randomized trials. The guidance that follows provides a general background and rationale for preparing oncology manuscripts for any journal. Many of these guidelines are based on feedback provided by actual peer reviewers. Even before you start writing, it is good practice to review the typical sections of a manuscript The text of observational and experimental articles is usually (but not necessarily) divided into sections with the headings Introduction, Methods, Results, and Discussion. This so-called "IMRAD". The abstract of the manuscript is usually divided into background, purpose, patients and methods, results and conclusion. The section on patients and methods of an oncology manuscript should include the eligibility criteria for the patients, study design, treatment plan, baseline and treatment assessments and statistical analysis. The results include data on patient characteristics, tumor response, time to event measures, toxicity and dose administration. The conclusion must address the primary objective of the study. Authors will be able to address up front many issues regarding content, organization, presentation, and formatting, thereby increasing the likelihood of successful publication of their papers in peer-reviewed journals.
发表成果可能代表着在学术医学领域的成就、研究数据的主要记录、通过撰写权威综述论文或书籍章节体现的专业能力证据,或者是实现学术晋升和职业发展的主要决定因素。编辑和审稿人喜欢收到易于阅读和编辑的稿件。期刊作者须知中的许多信息旨在以满足各期刊特定编辑需求的方式实现这一目标。《报告试验的统一标准》(CONSORT)声明是一项重要的研究工具,它采用循证方法来提高随机试验报告的质量。以下指南为向任何期刊投稿肿瘤学稿件提供了一般背景和基本原理。其中许多指南基于实际同行评审员提供的反馈。甚至在开始写作之前,审阅稿件的典型部分也是一种好习惯。观察性和实验性文章的正文通常(但不一定)分为引言、方法、结果和讨论等部分。这就是所谓的“IMRAD”。稿件的摘要通常分为背景、目的、患者和方法、结果及结论。肿瘤学稿件中患者和方法部分应包括患者的入选标准、研究设计、治疗方案、基线和治疗评估以及统计分析。结果包括患者特征、肿瘤反应、事件发生时间测量、毒性和剂量给药等数据。结论必须阐述研究的主要目的。作者将能够预先解决许多关于内容、组织、呈现和格式的问题,从而增加其论文在同行评审期刊上成功发表的可能性。